1. Home
  2. SNSE vs MKZR Comparison

SNSE vs MKZR Comparison

Compare SNSE & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • MKZR
  • Stock Information
  • Founded
  • SNSE 2005
  • MKZR 2012
  • Country
  • SNSE United States
  • MKZR United States
  • Employees
  • SNSE N/A
  • MKZR N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • MKZR
  • Sector
  • SNSE Health Care
  • MKZR
  • Exchange
  • SNSE Nasdaq
  • MKZR Nasdaq
  • Market Cap
  • SNSE 10.5M
  • MKZR 10.3M
  • IPO Year
  • SNSE 2021
  • MKZR N/A
  • Fundamental
  • Price
  • SNSE $9.02
  • MKZR $5.73
  • Analyst Decision
  • SNSE Strong Buy
  • MKZR
  • Analyst Count
  • SNSE 4
  • MKZR 0
  • Target Price
  • SNSE $72.50
  • MKZR N/A
  • AVG Volume (30 Days)
  • SNSE 8.3K
  • MKZR 35.8K
  • Earning Date
  • SNSE 11-13-2025
  • MKZR 11-11-2025
  • Dividend Yield
  • SNSE N/A
  • MKZR 39.41%
  • EPS Growth
  • SNSE N/A
  • MKZR N/A
  • EPS
  • SNSE N/A
  • MKZR N/A
  • Revenue
  • SNSE N/A
  • MKZR $23,037,348.00
  • Revenue This Year
  • SNSE N/A
  • MKZR N/A
  • Revenue Next Year
  • SNSE N/A
  • MKZR N/A
  • P/E Ratio
  • SNSE N/A
  • MKZR N/A
  • Revenue Growth
  • SNSE N/A
  • MKZR 52.64
  • 52 Week Low
  • SNSE $5.00
  • MKZR $3.89
  • 52 Week High
  • SNSE $17.40
  • MKZR $55.00
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 57.43
  • MKZR 50.07
  • Support Level
  • SNSE $7.93
  • MKZR $5.30
  • Resistance Level
  • SNSE $9.50
  • MKZR $5.90
  • Average True Range (ATR)
  • SNSE 0.57
  • MKZR 0.35
  • MACD
  • SNSE 0.09
  • MKZR 0.02
  • Stochastic Oscillator
  • SNSE 74.19
  • MKZR 39.15

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

About MKZR MacKenzie Realty Capital Inc.

Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.

Share on Social Networks: